Because of this and based on the outcome of our study regarding the involvement of p38 in JAZF1-SUZ12 fusion protein level regulation, we posit that p38 inhibition may ameliorate symptoms associated with PRC2 complex dysfunction observed in endometrial stromal sarcoma (ESS). Here, JAZF1 is linked to endometrioid stromal sarcoma.